Table V.
Analysis of risk factors associated with preoperative VTE in patients with endometrial cancer.
| Variables | VTE (−), n=188 | VTE (+), n=10 | P-value |
|---|---|---|---|
| Age (years), median (range) | 57 (23–85) | 69.5 (44–76) | 0.044 |
| Body mass index (kg/m2), median (range) | 22.5 (13.5–46.5) | 22.5 (20.8–26.3) | 0.444 |
| Stage, n (%) | 0.040 | ||
| I+II | 147 (78.2) | 5 (50.0) | |
| III+IV | 41 (21.8) | 5 (50.0) | |
| Histology, n (%) | 0.752 | ||
| Type 1 | 122 (64.9) | 6 (60.0) | |
| Type 2 | 66 (35.1) | 4 (40.0) | |
| Comorbidity, n (%) | 116 (61.7) | 5 (50.0) | 0.460 |
| Smoking, n (%) | 15 (8.0) | 0 (0.0) | 0.353 |
| Blood group, n (%) | 0.376 | ||
| O | 51 (27.1) | 4 (40.0) | |
| Non-O | 137 (62.9) | 6 (60.0) | |
| Leukocyte (/mm3), median (range) | 6260 (2090–18300) | 6670 (5110–10830) | 0.537 |
| Hemoglobin (g/dl), median (range) | 12.9 (2.9–15.9) | 13.1 (9.3–15.2) | 0.808 |
| Platelet (/mm3), median (range) | 26.7 (3.4–97.1) | 27.9 (22.0–46.6) | 0.247 |
| C-reactive protein (mg/dl), median (range) | 0.06 (0.0–9.5) | 0.07 (0.02–2.54) | 0.333 |
P-values were calculated using Mann-Whitney U or Chi-square tests. VTE, venous thromboembolism.